Novanta Inc. (LON:0VAG)

Market Cap	4.14B +44.5%
Revenue (ttm)	821.51M +13.2%
Net Income	40.16M +0.6%
EPS	0.98 -10.7%
Shares Out	n/a
PE Ratio	95.40
Forward PE	30.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,025
Open	132.54
Previous Close	144.76
Day's Range	120.00 - 135.23
52-Week Range	99.31 - 176.49
Beta	1.70
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 9, 2026

About Novanta

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment s...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1968
• Employees: 3,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0VAG

Financial Performance

In 2025, Novanta's revenue was $980.60 million, an increase of 3.30% compared to the previous year's $949.25 million. Earnings were $53.83 million, a decrease of -16.01%.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error